CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-01 | Furey John Director | Grant or award · Option to purchase Ordinary Shares | +500,000 | 500,000 | ||
| 2022-07-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +710,711 | 710,711 | ||
| 2022-07-01 | Sigal Charles Elliott Director | Grant or award · Option to purchase Ordinary Shares | +737,050 | 737,050 | ||
| 2022-07-01 | Duncan Barbara Gayle Director | Grant or award · Option to purchase Ordinary Shares | +500,000 | 500,000 | ||
| 2022-07-01 | MOTT DAVID M Director | Grant or award · Option to purchase Ordinary Shares | +1,000,439 | 1,000,439 | ||
| 2022-06-27 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,562 | $1.63 | $4K | 3,290 |
| 2022-05-20 | Wood Gavin Chief Financial Officer | Purchase | +39,000 | $0.29 | $11K | 96,000 |
| 2022-05-04 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +333,792 | 333,792 | ||
| 2022-05-04 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +223,512 | 223,512 | ||
| 2022-01-31 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +3,376,992 | 3,376,992 | ||
| 2022-01-31 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +754,200 | 754,200 | ||
| 2022-01-31 | Piccina Cintia Chief Commercial Officer | Grant or award · Option to purchase Ordinary Shares | +335,184 | 335,184 | ||
| 2022-01-18 | Bertrand William C JR Chief Operating Officer | Sale | −4,368 | $3.19 | $14K | 7,336 |
| 2022-01-18 | Lunger John Chief Patient Supply Officer | Sale | −4,368 | $3.19 | $14K | 7,336 |
| 2022-01-18 | Norry Elliot Chief Medical Officer | Sale | −2,121 | $3.19 | $7K | 3,529 |
| 2022-01-18 | Rawcliffe Adrian Chief Executive Officer | Sale | −11,096 | $3.19 | $35K | 12,312 |
| 2022-01-12 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2022-01-12 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2022-01-12 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2022-01-12 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 |
Page 9 of 23 · 454 trades